Polyrizon Ltd. Ordinary Shares

PLRZNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
12.80 USD
↘ 0.66 (4.90%)AT CLOSE (11:59 AM EDT)
13.02
↗ 0.22 (1.68%)
POST MARKET (AS OF 07:38 PM EDT)
Post Market
AS OF 07:38 PM EDT
13.02
↗ 0.22 (1.68%)
🔴Market: CLOSED
Open?$13.53
High?$13.92
Low?$12.80
Prev. Close?$13.46
Volume?26.4K
Avg. Volume?N/A
VWAP?$13.46
Bid / Ask
Bid?$10.83 × 100
Ask?$15.13 × 100
Spread?$4.30
Midpoint?$12.98
Valuation & Ratios
Market Cap?25.2M
Shares Out?1.9M
Float?1.6M
Float %?98.2%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A

Polyrizon Ltd. Ordinary Shares (PLRZ) is currently trading at $13.08. Technical indicators currently signal "Sell". This is driven by a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Jun 4, 2026.

News
Profile
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
Themes
Biotech - Drug Development›Infectious Disease & VaccinesNanotechnology & Advanced Materials›Nanomedicine & Drug Delivery
Employees
1
Market Cap
25.2M
Industry
N/A
Website
www.polyrizon-biotech.com
Listed
2024-10-29
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?2.37%Low
Short Interest?37.8K
Days to Cover?1.0
Free Float1.6M
Avg Daily Volume39.1K
Settlement Date2026-05-15
MarketsMoversWatchlist